#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14570	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2137	664.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1444	1444	C	920	C	813	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14570	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2137	664.1	0	HET	.	.	.	C326T	.	326	326	C	586	586	C	734	C,T	525,147	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14570	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2137	664.1	0	HET	.	.	.	C207T	.	207	207	C	467	467	C	761	C,T	553,110	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26622	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3794	685.7	0	.	n	.	0	T695C	SNP	695	695	T	1174	1174	C	1020	C	926	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26622	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3794	685.7	0	.	n	.	0	A1638G	SNP	1638	1638	A	2117	2117	G	653	G	594	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26622	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3794	685.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2450	2450	C	764	C	686	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26622	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3794	685.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2524	2524	A	827	A	721	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26622	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3794	685.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3076	3076	C	844	C	753	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1016	folP	855	855	100.0	folP.l15.c4.ctg.1	1512	64.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1058	1060	AGC	121;122;124	A;G;C	107;108;110	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	2528	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3462	70.5	1	SNP	p	S91F	1	.	.	271	273	TTC	625	627	TTC	71;71;71	T;T;C	68;68;68	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	2528	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3462	70.5	1	SNP	p	G95N	0	.	.	283	285	GGC	637	639	GGC	77;76;76	G;G;C	72;71;72	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	2528	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3462	70.5	1	SNP	p	D95G	1	.	.	283	285	GGC	637	639	GGC	77;76;76	G;G;C	72;71;72	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	798	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1298	58.6	1	SNP	p	G45D	0	.	.	133	135	GGC	451	453	GGC	93;94;94	G;G;C	89;90;90	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	574	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1019	54.7	0	.	n	.	0	A197.	DEL	197	197	A	598	598	A	118	A	111	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2428	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3026	77.4	1	SNP	p	D86N	0	.	.	256	258	GAC	629	631	GAC	108;108;109	G;A;C	103;102;105	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2428	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3026	77.4	1	SNP	p	S87R	1	.	.	259	261	CGT	632	634	CGT	109;109;109	C;G;T	105;103;104	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2428	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3026	77.4	1	SNP	p	R87I	0	.	.	259	261	CGT	632	634	CGT	109;109;109	C;G;T	105;103;104	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2428	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3026	77.4	1	SNP	p	R87W	0	.	.	259	261	CGT	632	634	CGT	109;109;109	C;G;T	105;103;104	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2428	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3026	77.4	1	SNP	p	S88P	0	.	.	262	264	TCC	635	637	TCC	110;111;110	T,C;C;C	103,1;107;105	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2006	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2685	71.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1532	1534	GGC	63;63;63	G;G;C	61;60;61	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	2702	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2309	113.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1256	1258	GCC	191;193;190	G;C;C	160;162;159	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2702	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2309	113.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1259	1261	ATG	178;176;176	A;T;G	152;151;150	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2702	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2309	113.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1271	1273	ACC	187;181;180	A;C;C	162;159;158	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2702	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2309	113.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1271	1273	ACC	187;181;180	A;C;C	162;159;158	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2702	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2309	113.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1772	1774	ACC	128;129;127	A;C;C	123;125;122	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2702	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2309	113.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1826	1828	GCG	104;105;109	G;C;G	97;96;99	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2702	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2309	113.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1826	1828	GCG	104;105;109	G;C;G	97;96;99	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2702	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2309	113.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1949	1951	GGT	49;49;49	G;G;T	49;49;49	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2702	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2309	113.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1958	1960	AGC	40;40;40	A;G;C	40;40;40	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2702	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2309	113.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1976	1978	CCG	27;23;24	C;C;G	27;23;23	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4574	ponA	2397	2397	100.0	ponA.l6.c17.ctg.1	3230	136.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1719	1721	CCG	73;72;72	C;C;G	68;68;65	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1054	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1884	53.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	637	637	C	63	C,T	54,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	1728	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1864	90.4	1	SNP	p	G120K	1	.	.	358	360	AAG	763	765	AAG	130;130;134	A;A;G	114;114;118	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	1728	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1864	90.4	1	SNP	p	A121N	1	.	.	361	363	AAC	766	768	AAC	135;133;135	A;A;C	119;118;119	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	1728	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1864	90.4	1	SNP	p	N121D	0	.	.	361	363	AAC	766	768	AAC	135;133;135	A;A;C	119;118;119	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	6546	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4864	131.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	560	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1023	53.0	1	SNP	p	V57M	1	.	.	169	171	ATG	535	537	ATG	89;92;94	A;T;G	79;81;84	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
